ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1787

Increased Heart Rate Variability Reflects Improvement in Clinical Status of Patients with Systemic Lupus Erythematosus

Aikaterini Thanou1, Stavros Stavrakis2, John W. Dyer2, Stan Kamp3, Judith A. James4 and Joan T. Merrill3, 1Arthritis and Clinical Immunology Reseach Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, OK, 4Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Disease Activity and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Decreased heart rate variability (HRV) is a sign of potentially serious cardiac morbidity and is known to reflect autonomic dysfunction and inflammatory dysregulation (1). We have previously reported a cross-sectional association as well as association of changes between disease activity and HRV in patients with systemic lupus erythematosus (SLE) (2). We have not however yet demonstrated a predictable temporal relationship over time between SLE disease activity and HRV in individual patients.

Methods:  To prospectively test the hypothesis that clinical improvement is reflected by increased HRV, we designed an ongoing clinical trial to include HRV measurements using a 5 min ECG and HRV parameters calculated in the time domain (RMSSD and pNN50) and frequency domain [high frequency (HF) and the low frequency to high frequency (LF/HF) ratio]. Here we report findings from 32 SLE patients (31 female, age 46.2 +/- 10.9) who have completed a minimum of 2 visits to date. A mixed effects linear model was used to compare the change in HRV parameters between 83 paired visits. Two groups were compared, those with clinical improvement between visits (group 1) and those with same or worse disease activity (group 2). Clinical improvement was defined as >/= 1 letter grade improvement in BILAG between visits with no new BILAG A or B scores.

Results:  There was improvement in 14 (17%) of the paired, consecutive visits and no improvement or worsening in 69 (83%) visits. An inverse relationship was observed between clinical improvement and change in RMSSD, change in pNN50 and % change in HF (Table 1). The LF/HF ratio increased significantly between visits of patients in group 1 and decreased between visits in group 2 (4.51±1.95% vs. -0.14±0.83%, respectively; p=0.031).

Conclusion: HRV changes reflect changes in clinical status over time in patients with SLE. These data suggest that HRV may be a simple non-invasive tool for tracking clinical improvement and underscore the role of the autonomic nervous system in inflammatory pathways. Table 1.

Variable Group 1 visits (n=14) Group 2 visits (n=69) P-value
Delta RMSSD (ms) -87.6±39.4 7.1±17.7 0.027
Delta pNN50 (ms) -3.18±2.03 0.02±0.92 0.15
Delta HF (%) -27.0±8.4 -5.7±3.6 0.022
Delta LF/HF (%) 4.51±1.95 -0.14±0.83 0.031

References:

  1. Tracey KJ. The inflammatory reflex. Nature. 2002;4206917:853-9.
  2. Thanou A, Stavrakis S, Dyer J, Kamp S, Munroe ME, Albert D, James JA, Merrill JT. Heart Rate Variability Is Associated with SLE Flare and with TNF- and IFN-Mediated Signaling. American College of Rheumatology Annual Scientific Meeting. San Francisco, CA. November 7-11, 2015.

Disclosure: A. Thanou, None; S. Stavrakis, None; J. W. Dyer, None; S. Kamp, None; J. A. James, None; J. T. Merrill, Lilly, Anthera, GSK, UCB, BMS, EMD Serono, Celgene, Biogen, Takeda, Seattle Genetics Abbvie, Questcor, 5,BMS, GSK, Pfizer, 2.

To cite this abstract in AMA style:

Thanou A, Stavrakis S, Dyer JW, Kamp S, James JA, Merrill JT. Increased Heart Rate Variability Reflects Improvement in Clinical Status of Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/increased-heart-rate-variability-reflects-improvement-in-clinical-status-of-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-heart-rate-variability-reflects-improvement-in-clinical-status-of-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology